Treatment with mesalamine significantly increased Nrf2 and HO‐1 levels by 3.01‐fold (F = 128.2, p = 0.0003) and 1.79‐fold (F = 141.7, p = 0.02), respectively, relative to the colitis group. Here, HMOX1 is linked to colitis.